The 10 Most Innovative Companies Bringing AI to Healthcare The 10 Most Innovative Companies Bringing AI to He | Page 38

Wireless Pulse Oximeter
For decades now, we all are quite habituated with the
pulse Oximeter that is one of the most widely used
devices for monitoring patients. This function
measures the level of oxygen saturation in a blood
that is very critical while performing operations and
complex medical procedures. However, the advent of
wireless personal pulse oximetry devices in 2016 has
driven the sales volume to new heights. Originated in
France, ‘MyOxy’ monitor is a Bluetooth-enabled
device that integrates oxygen saturation along with
other parameters like temperature, blood pressure
into a smartphone or a tablet. The other one –
‘MightySat’ was invented in the US and is also a
Bluetooth-based device that can be connected to an
Apple or Android application. This home-use device
tracks the vital information while they are in motion.
Daurismo Blood Cancer Drug
One of the premier pharmaceutical companies –
Pfizer is planning to launch a drug in the US that
treats a form of blood cancer in newly-diagnosed
patients under a ‘combination therapy’. The FDA
recently approved the drug to be used for adults
suffering from ‘acute myeloid leukemia’ (AML) for
patients aged 75 or more. This treatment is also
restricted to the patients who have certain health
conditions prior to receiving the diagnosis and
secondly on whom intensive chemotherapy is not a
feasible option.
Recent research on AMD
Age-related macular degeneration blurs the part of the eye called ‘macula’ that allows a person to perform
‘straight-head’ activities like driving, reading, to name a few. Although it doesn’t convert to complete
blindness, with time the eyes develop blank spots in the central vision that hugely impacts the eye-sight.
Recently, a team at the University of Pennsylvania has categorized a new animal model that impersonates
the aspects of AMD. This model will assist the researchers to explore and probe the environmental risk
factors that stimulate this disease and that can eventually help them to design a successful treatment
accordingly.
- Devasish Kanojiya
36
DECEMBER 2018